SOPHiA GENETICS (SOPH) CFO George Cardoza Sells Shares

What Happened
George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), sold 1,403 shares in an open-market transaction on April 8, 2026. The weighted-average sale price was $4.85 per share for total proceeds of about $6,801. The filing shows this was a sale (code S) to satisfy tax withholding obligations tied to the vesting of restricted stock units.

Key Details

• Transaction date: April 8, 2026; Form 4 filed April 10, 2026 (appears timely).
• Shares sold: 1,403; weighted-average price reported: $4.85; price range: $4.79–$4.93.
• Total proceeds: ~$6,801.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes: Sale was effected pursuant to a pre-established Rule 10b5‑1 trading plan and made to satisfy tax withholding on RSU vesting (non-discretionary). The filer can provide a breakdown of the number of shares sold at each price in the reported range upon request.

Context
This was a routine, small-value sale to cover tax withholding for vested RSUs and was carried out under a pre-set 10b5‑1 plan—actions like this are common and do not necessarily indicate a change in the insider’s view of the company. Purchases generally carry more weight as signals than routine tax-withholding sales.